Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
17.24
-0.42 (-2.35%)
At close: Apr 4, 2025, 4:00 PM
17.01
-0.23 (-1.31%)
After-hours: Apr 4, 2025, 7:58 PM EDT

Rigel Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
308296253259453591
Upgrade
Market Cap Growth
17.18%17.18%-2.48%-42.79%-23.38%64.89%
Upgrade
Enterprise Value
331335295269403560
Upgrade
Last Close Price
17.2416.8214.5015.0026.5035.00
Upgrade
PE Ratio
17.4116.95----
Upgrade
Forward PE
14.8917.39----
Upgrade
PS Ratio
1.691.652.182.243.275.45
Upgrade
PB Ratio
92.8690.11-8.83-19.0414.9217.38
Upgrade
P/TBV Ratio
----14.9217.38
Upgrade
P/FCF Ratio
9.809.43--86.30-
Upgrade
P/OCF Ratio
9.799.41--77.10-
Upgrade
EV/Sales Ratio
1.841.872.552.332.905.15
Upgrade
EV/EBITDA Ratio
12.5112.69----
Upgrade
EV/EBIT Ratio
13.6613.86----
Upgrade
EV/FCF Ratio
10.5210.67--76.67-
Upgrade
Debt / Equity Ratio
30.4030.40-3.64-6.443.011.15
Upgrade
Debt / EBITDA Ratio
3.683.68----
Upgrade
Debt / FCF Ratio
3.183.18--17.38-
Upgrade
Asset Turnover
1.271.270.920.771.000.84
Upgrade
Inventory Turnover
5.495.492.765.1710.8212.21
Upgrade
Quick Ratio
1.881.881.641.512.211.80
Upgrade
Current Ratio
2.132.131.861.782.432.18
Upgrade
Return on Equity (ROE)
----699.04%-55.63%-67.72%
Upgrade
Return on Assets (ROA)
10.75%10.75%-10.68%-24.34%-8.77%-14.04%
Upgrade
Return on Capital (ROIC)
16.92%16.92%-17.95%-37.50%-12.50%-22.19%
Upgrade
Return on Capital Employed (ROCE)
24.00%24.00%----
Upgrade
Earnings Yield
5.68%5.90%-9.92%-22.59%-3.95%-5.03%
Upgrade
FCF Yield
10.21%10.61%-2.27%-28.62%1.16%-9.04%
Upgrade
Buyback Yield / Dilution
-1.64%-1.64%-2.07%0.00%-1.03%-0.81%
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q